New naltrexone formulation may benefit alcoholics

03/20/2008 | Reuters

A U.S. study showed that alcohol-dependent patients were able to cut down on drinking within two days of receiving an intramuscular extended-release version of naltrexone, an anti-addiction drug. The findings may help patients get earlier treatment and "focus on the goals established in counseling," the researchers said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD